Upload
datatrak-international-inc
View
742
Download
0
Embed Size (px)
DESCRIPTION
Presentation discusses: The Drug Development Process The Drug Development Paradox Regulations and Guidelines Standards - CDISC Leveraging Technology Resource Management
Citation preview
Utilizing a Unified Platform to Bridge Geographical
and Departmental Gaps While Expediting an Entire
Development ProgramPresented to DIA-Japan: 31 January 2014
William Gluck, Ph.D.
Confidential – 2
Disclaimer
► The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Special Interest Area Communities or affiliates, or any organization with which the presenter is employed or affiliated.
► These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. Drug Information Association, Drug Information Association Inc., DIA and DIA logo are registered trademarks. All other trademarks are the property of their respective owners.
Confidential – 3
Agenda
1. The Drug Development Process
2. The Drug Development Paradox
3. Regulations and Guidelines
4. Standards – CDISC
5. Leveraging Technology
6. Resource Management
Confidential – 4
Overview – The Drug Development Process
Confidential – 5
The Clinical Trial ParadoxLeverage technology and process to conduct trials faster and obtain quicker approvals
With speed and more interaction comes a greater risk of error
Confidential – 6
Downstream Data Quality at RiskOver time, seemingly insignificant errors accumulate, significantly increasing risk
Combined Human Interaction and Speed in the Clinical Trial Process…
Potential for Error = Increased Risk
Discovery
10 years 3.5 years 6.5 years
Clinical
Pre-Clinical
Confidential – 7
How can we reduce the time needed to conduct studies
and also reduce risk? Regulations &
Guidelines Standards - CDISC Leveraging
Technology Resource
Management
Confidential – 8
Regulations and Guidelines Help to Accelerate Drug
Development and Reduce Risk
Standardized Data and Process
GCP
ICHFDA
Confidential – 9
Standards
CDISC
CDASH ODM STDM AdAM SHAR
E
Leveraging Technology
Confidential – 11
The Integrated Approach
Data must be moved in order to create the central database – increases risk of errors
Central Databa
se
EDC
Randomization
Coding
Confidential – 12
The Unified
Approach
Reduces risk
Central Databas
e
EDC
Coding
Randomization
Resource Management
Confidential – 14
Key Roles and Responsibilities
• Overall support and guidanceClinical R&D Leadership
• Develop Study-specific/Development PlanClinical Study
Team
• Centrally monitor quality across all sites – identify emerging issues
• Coordinate/track and follow-up
CRA/Site Quality
Manager• Data Management Plan – Targeted & Aligned• EDC configuration as a key enabler• Global Data and System Management
Data Management
Confidential – 15
Inter-Relationships
Using the Unified Platform – Everything in one place
• CDM• CRA
• Clinical Study Team
• Clinical R&D
Regulations
Standards
Technology
Resources
Confidential – 16
Utilizing All Resources
Central Data Repository
Resources
Technology
Standards
Confidential – 17
Real Life Example: Value of the Central Repository and Unified Platform
► Drug A: Generation of the ISS and ISE• Different vendors, databases, standards• Time duration: 10 months to generate
► Drug B: Generation of the ISS and ISE• Different CRO vendors for Phase I• Single vendor, single platform database for
Phase II and Phase III studies• Standards enforced (but not CDISC)• Time duration: 4 months to generate
Confidential – 18
Summary
How can we reduce the time needed to conduct studies and also reduce risk?
• Leverage Regulations and Standards• Leverage Technology – Reduce
Movement by using a Unified Platform• Leverage Resources – Adjust Roles to
Maximize Effectiveness
Confidential – 19
William Gluck, Ph.D.
VP, DATATRAK Clinical Knowledge
DATATRAK
Phone: 440-443-0082 x114
E-Mail: [email protected]
from Concept to Cure
with DATATRAK ONE
DATATRAK InternationalCleveland, Ohio Bryan, Texas Cary, North Carolina
888.677.DATA (3282) Toll Freewww.datatrak.net
®
™